UAMY Stock Soars to 52-Week High, Hits $2.18 Amidst Stunning Annual Surge

Published 2024-12-16, 10:52 a/m
UAMY
-

In a remarkable display of market momentum, United States Antimony Corp (UAMY) stock has reached a 52-week high, touching a price level of $2.18. According to InvestingPro data, the company maintains a healthy liquidity position with a current ratio of 6.24 and operates with moderate debt levels. This peak represents a significant milestone for the company, which has seen an extraordinary 1-year change, with its stock value skyrocketing by 719.81%. While revenue grew by 28.4% in the last twelve months, InvestingPro analysis reveals challenges with negative gross profit margins and profitability. Investors have rallied behind UAMY, propelling the stock to new heights as the company capitalizes on favorable market conditions and strategic business moves that have resonated positively with the market sentiment. The 52-week high serves as a testament to the company's robust performance over the past year, marking a period of exceptional growth and investor confidence. For deeper insights into UAMY's valuation and growth prospects, including 13 additional ProTips, check out the comprehensive Pro Research Report available on InvestingPro.

In other recent news, United States Antimony Corporation has reported a 23% sales increase to $8.1 million for the first nine months ending September 30, 2024, and a 107% rise in gross profit to $2.2 million. H.C. Wainwright initiated coverage on the company with a Buy rating and a price target of $2.50, citing the firm's resilience and versatility in the industry. The company's recent acquisitions of mining claims in Alaska and Ontario have significantly bolstered its reserves of critical minerals.

United States Antimony Corporation has also been engaging with U.S. government officials for potential sales and funding and is negotiating contracts to secure new antimony supplies due to increased restrictions in China. The company is preparing to meet increased demand for domestic antimony supplies by 2027 and is exploring potential government grants and collaborations.

However, the company's zeolite business faced a gross profit decline of $255,000 due to higher maintenance costs and it incurred a loss from discontinued operations in Mexico. Despite these challenges, the company remains focused on producing antimony material by 2025, targeting high-grade deposits to minimize costs.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.